All Journals > The Journal of Infectious Diseases > 1 March 2008 > Microarray Gene Expression Profiles in CAEBV Infection

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 March 2008

Volume 197, Number 5
The Journal of Infectious Diseases 2008;197:663–666
0022-1899/2008/19705-0008$15.00
DOI: 10.1086/527330
BRIEF REPORT

Oligonucleotide Microarray Analysis of Gene Expression Profiles followed by Real‐Time Reverse-Transcriptase Polymerase Chain Reaction Assay in Chronic Active Epstein‐Barr Virus Infection

Yoshinori Ito,1

Yukiko Shibata‐Watanabe,1

Yoko Ushijima,2

Jun‐ichi Kawada,1

Yukihiro Nishiyama,2

Seiji Kojima,1 and

Hiroshi Kimura2

1 Department of Pediatrics and 2 Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Chronic active Epstein‐Barr virus infection (CAEBV) is characterized by recurrent infectious mononucleosis–like symptoms and has high mortality and morbidity. To clarify the mechanisms of CAEBV, the gene‐expression profiles of peripheral blood obtained from patients with CAEBV were investigated. Twenty genes were differentially expressed in 4 patients with CAEBV. This microarray result was verified using a real‐time reverse-transcriptase polymerase chain reaction assay in a larger group of patients with CAEBV. Eventually, 3 genes were found to be significantly upregulated: guanylate binding protein 1, tumor necrosis factor–induced protein 6, and guanylate binding protein 5. These genes may be associated with the inflammatory reaction or with cell proliferation.

Received 19 June 2007; accepted 24 September 2007; electronically published 8 February 2008.

Reprints or correspondence: Hiroshi Kimura, MD, PhD, Department of Virology, Nagoya University Graduate School of Medicine, 65 Tsurumai‐cho, Showa‐ku, Nagoya 466–8550, Japan ().

Cited by

Jeffrey I. Cohen. (2008) Optimal treatment for chronic active Epstein-Barr virus disease. Pediatric Transplantation
Online publication date: 1-Dec-2008.
CrossRef
  • Presented in part: 32nd International Herpesvirus Workshop, Asheville, North Carolina, 7–12 July 2007 (abstract 3.13).

    Potential conflicts of interest: none reported.

    Financial support: Japan Society for the Promotion of Science (Grant‐in‐Aid for Scientific Research [C] [18591212] to Y.I.).

Close Popup